Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:145875rdf:typepubmed:Citationlld:pubmed
pubmed-article:145875lifeskim:mentionsumls-concept:C0521451lld:lifeskim
pubmed-article:145875lifeskim:mentionsumls-concept:C0001412lld:lifeskim
pubmed-article:145875lifeskim:mentionsumls-concept:C1153663lld:lifeskim
pubmed-article:145875lifeskim:mentionsumls-concept:C0001475lld:lifeskim
pubmed-article:145875lifeskim:mentionsumls-concept:C0439792lld:lifeskim
pubmed-article:145875lifeskim:mentionsumls-concept:C0014639lld:lifeskim
pubmed-article:145875pubmed:issue2lld:pubmed
pubmed-article:145875pubmed:dateCreated1978-3-21lld:pubmed
pubmed-article:145875pubmed:abstractText1. The use of 1,N6-ethenoadenosine 5'-triphosphate (epsilon-ATP), a synthetic, fluorescent analog of ATP, by whole rat liver mitochondria and by submitochondrial particles produced via sonication has been studied. 2. Direct [3H]adenine nucleotide uptake studies with isolated mitochondria, indicate the epsilon-[3H]ATP is not transported through the inner membrane by the adenine nucleotide carrier and is therefore not utilized by the 2,4-dinitrophenol-sensitive F1-ATPase (EC 3.6.1.3) that functions in oxidative phosphorylation. However, epsilon-ATP is hydrolyzed by a Mg2+-dependent, 2,4-dinitrophenol-insensitive ATPase that is characteristic of damaged mitochondria. 3. epsilon-ATP can be utilized quite well by the exposed F1-ATPase of sonic submitochondrial particles. This epsilon-ATP hydrolysis activity is inhibited by oligomycin and stimulated by 2,4-dinitrophenol. The particle F1-ATPase displays similar Km values for both ATP and epsilon-ATP; however, the V with ATP is approximately six times greater than with epsilon-ATP. 4. Since epsilon-ATP is a capable substrate for the submitochondrial particle F1-ATPase, it is proposed that the fluorescent properties of this ATP analog might be employed to study the submitochondrial particle F1-ATPase complex, and its response to various modifiers of oxidative phosphorylation.lld:pubmed
pubmed-article:145875pubmed:languageenglld:pubmed
pubmed-article:145875pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:145875pubmed:citationSubsetIMlld:pubmed
pubmed-article:145875pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:145875pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:145875pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:145875pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:145875pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:145875pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:145875pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:145875pubmed:statusMEDLINElld:pubmed
pubmed-article:145875pubmed:monthFeblld:pubmed
pubmed-article:145875pubmed:issn0006-3002lld:pubmed
pubmed-article:145875pubmed:authorpubmed-author:KaplanR SRSlld:pubmed
pubmed-article:145875pubmed:authorpubmed-author:ColemanP SPSlld:pubmed
pubmed-article:145875pubmed:issnTypePrintlld:pubmed
pubmed-article:145875pubmed:day9lld:pubmed
pubmed-article:145875pubmed:volume501lld:pubmed
pubmed-article:145875pubmed:ownerNLMlld:pubmed
pubmed-article:145875pubmed:authorsCompleteYlld:pubmed
pubmed-article:145875pubmed:pagination269-74lld:pubmed
pubmed-article:145875pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:145875pubmed:meshHeadingpubmed-meshheading:145875-A...lld:pubmed
pubmed-article:145875pubmed:meshHeadingpubmed-meshheading:145875-R...lld:pubmed
pubmed-article:145875pubmed:meshHeadingpubmed-meshheading:145875-A...lld:pubmed
pubmed-article:145875pubmed:meshHeadingpubmed-meshheading:145875-M...lld:pubmed
pubmed-article:145875pubmed:meshHeadingpubmed-meshheading:145875-A...lld:pubmed
pubmed-article:145875pubmed:meshHeadingpubmed-meshheading:145875-M...lld:pubmed
pubmed-article:145875pubmed:meshHeadingpubmed-meshheading:145875-O...lld:pubmed
pubmed-article:145875pubmed:meshHeadingpubmed-meshheading:145875-D...lld:pubmed
pubmed-article:145875pubmed:meshHeadingpubmed-meshheading:145875-N...lld:pubmed
pubmed-article:145875pubmed:meshHeadingpubmed-meshheading:145875-B...lld:pubmed
pubmed-article:145875pubmed:meshHeadingpubmed-meshheading:145875-O...lld:pubmed
pubmed-article:145875pubmed:meshHeadingpubmed-meshheading:145875-C...lld:pubmed
pubmed-article:145875pubmed:meshHeadingpubmed-meshheading:145875-S...lld:pubmed
pubmed-article:145875pubmed:meshHeadingpubmed-meshheading:145875-E...lld:pubmed
pubmed-article:145875pubmed:meshHeadingpubmed-meshheading:145875-M...lld:pubmed
pubmed-article:145875pubmed:year1978lld:pubmed
pubmed-article:145875pubmed:articleTitleThe extent of mitochondrial F1-ATPase and adenine nucleotide carrier activity with epsilon-ATP.lld:pubmed
pubmed-article:145875pubmed:publicationTypeJournal Articlelld:pubmed